SWAV实时信号 | 通过Getagraph.com最大化利润

购买 62 min ago

@ $329.28

发出时间: 29 Apr 2024 @ 22:57

回报率: 0.15%

上一信号: Apr 26 - 23:58

上一信号: 出售

回报率: 0.03 %

Live Chart Being Loaded With Signals

Commentary (30 Apr 2024 @ 00:00):

Stats
今日成交量	115 569
平均成交量	1.07M
市值	12.37B
EPS	$0 ( 2024-02-15 )
下一个收益日期	( $1.040 ) 2024-05-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	85.44
ATR14	$0.943 (0.29%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-26	Francis Laura	Sell	1 500	Stock Option
2024-03-26	Francis Laura	Buy	1 500	Common Stock
2024-03-26	Francis Laura	Sell	1 500	Common Stock
2024-03-26	Francis Laura	Buy	1 500	Common Stock
2024-03-26	Francis Laura	Sell	1 500	Common Stock

INSIDER POWER
-13.77
Last 99 transactions
Buy: 225 001 \| Sell: 293 391

音量相关性

長: 0.11 (neutral)

短: 0.75 (moderate)

Signal:(55) Neutral

Shockwave Medical Inc 相关性

10 最正相关
ASPS	0.951
NKTX	0.95
RPID	0.948
GOSS	0.939
RTPY	0.938
QLGN	0.937
LGMK	0.934
USCB	0.931
LYRA	0.927
SWVL	0.926

10 最负相关
NWFL	-0.966
MLCO	-0.962
TCOM	-0.961
PEBK	-0.958
IMVT	-0.953
FXCO	-0.946
CBAY	-0.945
LUNA	-0.945
HCM	-0.944
HZNP	-0.943

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Shockwave Medical Inc 相关性 - 货币/商品

0.08
( neutral )

-0.10
( neutral )

0.00
( neutral )

0.20
( neutral )

-0.19
( neutral )

-0.07
( neutral )

Shockwave Medical Inc 财务报表

Annual	2023
营收:	$730.23M
毛利润:	$634.84M (86.94 %)
EPS:	$4.01

FY	2023
营收:	$730.23M
毛利润:	$634.84M (86.94 %)
EPS:	$4.01

FY	2022
营收:	$489.73M
毛利润:	$424.74M (86.73 %)
EPS:	$6.02

FY	2021
营收:	$237.15M
毛利润:	$195.71M (82.53 %)
EPS:	$-0.276

Financial Reports:

No articles found.

Shockwave Medical Inc

ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease (PAD); C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee PAD. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.